Ruth Capital Bublan Pashayaban tells investors in a research note that the intention of the Food and Drug Administration (FDA DaraoOCel in its current form. The company repeats a purchase classification and $ 31 The target price On Capricor shares.
First published on Thefly -The final source of the actual time, the financial financial news in the market. Try now >>
Watch today’s best -performance shares on Tipranks >>
Read more on CAPR:
The post No Ad Comm ‘not necessarily positive’ for Capricor, says Roth Capital first appeared on Investorempires.com.
